It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Here's the deal. Researchers at the University of Alberta in Edmonton, Canada found a cheap and easy to produce drug that kills almost all cancers. The drug is dichloroacetate, and since it is already used to treat metabolic disorders, we know it should be no problem to use it for other purposes.
*snip*
Scientists tested DCA on human cells cultured outside the body where it killed lung, breast and brain cancer cells, but left healthy cells alone. Rats plump with tumors shrank when they were fed water supplemented with DCA.
All I can do is write this and hope Google News picks it up. In the meantime, tell everyone you know and do your own research.
DCA attacks a unique feature of cancer cells: the fact that they make their energy throughout the main body of the cell, rather than in distinct organelles called mitochondria. This process, called glycolysis, is inefficient and uses up vast amounts of sugar.
Until now it had been assumed that cancer cells used glycolysis because their mitochondria were irreparably damaged. However, Michelakis’s experiments prove this is not the case, because DCA reawakened the mitochondria in cancer cells. The cells then withered and died (Cancer Cell, DOI: 10.1016/j.ccr.2006.10.020).
In findings that "astounded" the researchers, the molecule known as DCA was shown to shrink lung, breast and brain tumours in both animal and human tissue experiments.
Originally posted by carslake
I think its going to annoy the Big Pharmaceutical companies.
$2 a dose wheres the profit in that.
.
Let's hope they move ahead quickly. The Canadian medical system is different than that of the US. I'm not sure how they get drugs approved for treatment.
Originally posted by G_man
I've read about this in a couple of places and it sounds pretty interesting. Here is a link to New Scientist which has a story on it.
The patent issue is not that it can't be patented but rather that the patent for the drug has expired so now it can be produced by anybody rather than by the patent holder at an inflated price.
New Scientist